Hospital News and Research

RSS

SHS exposure associated with psychological distress, risk of future psychiatric illness: UCL research

Second hand smoke exposure is associated with psychological distress and risk of future psychiatric illness, according to new UCL research that suggests the harmful affects of passive smoking go beyond physical health.

8 Jun 2010

Hospira signs licensing agreement to develop and market DURECT's POSIDUR

Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and DURECT Corporation, a specialty pharmaceutical company, today announced that the companies have entered into a licensing agreement to develop and market DURECT's POSIDUR (SABER-bupivacaine) a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials.

8 Jun 2010

U.S. Renal Care acquires Dialysis Corporation of America for $110.25M

U.S. Renal Care, Inc., a leading privately-held provider of outpatient dialysis services, today announced that it has completed its $110.25 million acquisition of Dialysis Corporation of America, Inc., a leading provider of outpatient kidney dialysis services. With this acquisition, USRC will provide dialysis services to approximately 5,500 patients and operate 84 dialysis centers, home and specialty hospital dialysis programs and facilities in nine states: Arkansas, Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, Texas, and Virginia.

8 Jun 2010

Lawsuit to be launched over breast cancer gene patent

BRCA1 and BRCA2 are two genes that have been identified to hold a key to women’s susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.

7 Jun 2010

MHRA issues Supplementary Accreditation to Chiltern

Chiltern International Limited, a global contract research organization, has announced that Chiltern Early Phase Limited, based in Ninewells Hospital and Medical School in Dundee, Scotland, has achieved Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency.

7 Jun 2010

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.

7 Jun 2010

Oslo University Hospital, Induct announce long term strategic partnership Agreement

Oslo University Hospital and Induct Software AS, "The Open Innovation Company," today announced a long term strategic partnership Agreement under which the parties will work together to help Oslo University Hospital achieve its goal of becoming the world leader in healthcare innovation.

7 Jun 2010

UBMD selects Allscripts EHR solution to help its physicians enhance quality of patient care

Allscripts announced today that UBMD has selected the Allscripts Electronic Health Record solution to help its 450 physicians enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.

7 Jun 2010

Watermark Medical completes $15M equity investment from CA Technologies

Watermark Medical, Inc., a privately-held medical products and services company currently servicing the sleep-disordered breathing market, today announced the completion of a $15 million equity investment from CA Technologies. This equity investment in Watermark Medical represents CA Technologies' entry into the emerging Software-as-a-Service -based healthcare cloud market.

7 Jun 2010

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.

7 Jun 2010

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB) through LRP-1 targeting, announced today that complete phase 1/2 clinical data in two clinical studies of its lead oncology program, ANG1005, for the treatment of brain cancers, including glioblastoma (GBM) and brain metastases, were presented at the 2010 American Society for Clinical Oncology (ASCO) Annual Meeting, June 4-8, in Chicago, IL.

7 Jun 2010

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today preliminary clinical data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.

7 Jun 2010

SEMHIE wins $3M contract for Social Security Administration's electronic medical records initiative

The Southeast Michigan Health Information Exchange announced today that it has won a $2,988,000 contract for an electronic medical records initiative from the Social Security Administration. This award comes to SEMHIE in partnership with its fiduciary, Southeastern Michigan Health Association and its project partners CNSI, The Object Management Group™, Computer Sciences Corporation and Oracle/Sun Microsystems.

7 Jun 2010

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine continues to produce promising efficacy results in patients with previously untreated, inoperable, locally advanced or metastatic pancreatic cancer.

7 Jun 2010

Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

Guardian Home Care Holdings, Inc., a leading provider of home care and hospice services, announced it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to patients with chronic illnesses. Cardiocom is a developer, manufacturer and clinical service provider of award-winning telehealth solutions.

7 Jun 2010

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

CSC announced today that Lorenzo Regional Care Release 1.9 went live on June 1, 2010 at the University Hospitals of Morecambe Bay NHS Trust, with the implementation completed on June 3, 2010.

7 Jun 2010

MKMG implements CoActiv Medical's EXAM-VAULT QUAD-REDUNDANT ARCHIVING solution

Mount Kisco Medical Group (MKMG), the largest multi-specialty medical group in New York state, has selected CoActiv Medical's EXAM-VAULT® QUAD-REDUNDANT ARCHIVING® solution for the storage of its multi-modality imaging exams.

7 Jun 2010

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.

7 Jun 2010

Clinical trial data of imetelstat in patients with breast cancer presented at ASCO annual meeting

Geron Corporation today announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology annual meeting in Chicago.

7 Jun 2010

SCCT names finalists of fourth annual Young Investigator Award

The Society of Cardiovascular Computed Tomography, the leading international professional society dedicated to research, education and clinical excellence in cardiovascular computed tomography, has named the finalists of the fourth annual Young Investigator Award. Sponsored by Toshiba America Medical Systems, Inc. through an unrestricted educational grant, the Young Investigator Award will be awarded to two residents or fellows in either radiology or cardiology for their patient care research in the categories of technical and clinical advancement of cardiovascular CT.

7 Jun 2010

Hospital News and Research

SHS exposure associated with psychological distress, risk of future psychiatric illness: UCL research

Hospira signs licensing agreement to develop and market DURECT's POSIDUR

U.S. Renal Care acquires Dialysis Corporation of America for $110.25M

Lawsuit to be launched over breast cancer gene patent

MHRA issues Supplementary Accreditation to Chiltern

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

Oslo University Hospital, Induct announce long term strategic partnership Agreement

UBMD selects Allscripts EHR solution to help its physicians enhance quality of patient care

Watermark Medical completes $15M equity investment from CA Technologies

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

SEMHIE wins $3M contract for Social Security Administration's electronic medical records initiative

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

MKMG implements CoActiv Medical's EXAM-VAULT QUAD-REDUNDANT ARCHIVING solution

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

Clinical trial data of imetelstat in patients with breast cancer presented at ASCO annual meeting

SCCT names finalists of fourth annual Young Investigator Award

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News